Serina Therapeutics SER Cash Flow Statement (2018-2026)

NYSE SER
$2.63 -0.14 (-5.05%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income (Quarter)
0.01M-0.01M-2.71M-2.62M-2.44M-1.78M-1.05M-1.05M-1.56M0.43M-3.00M-4.48M-5.43M-5.91M-6.29M-5.96M-6.42M-6.38M-8.73M
Depreciation and Depletion (Quarter)
0.01M0.02M0.03M0.22M0.02M0.09M0.02M
Share-based Compensation (Quarter)
0.29M0.27M-0.72M0.24M0.20M0.21M0.11M0.00M0.02M0.04M-0.03M36.40M0.46M36.40M-36.40M2.85M-2.85M
Cash from Discontinued Operations (Quarter)
Gains from Investment Securities (Quarter)
0.09M0.17M-0.04M0.01M-0.17M-0.29M-0.60M-0.02M-5.58M-9.30M-6.67M-2.77M-0.99M0.96M-1.00M-3.22M
Cash from Operations (Quarter)
-1.78M-1.79M-1.74M-1.64M-1.75M-1.24M-1.32M-0.71M-0.86M-1.02M0.12M-1.58M-8.01M-2.96M-4.59M-4.32M-3.75M-3.83M-6.05M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)
0.27M0.28M0.29M0.54M0.81M0.87M0.92M1.06M0.92M-1.98M0.02M0.31M0.01M0.01M0.06M
Depreciation & Amortization (CF) (Quarter)
0.01M0.02M0.05M0.01M0.03M0.06M0.06M0.06M0.02M0.02M0.02M0.02M0.02M
Change in Working Capital
Change in Receivables (Quarter)
-0.04M0.01M0.00M-0.03M0.01M-0.01M0.00M0.00M-0.00M0.06M-0.01M
Change in Account Payables (Quarter)
-0.31M-0.31M0.02M-0.67M-0.33M0.06M-0.77M1.23M-0.13M0.24M-1.45M0.49M-0.95M0.44M0.52M1.04M-0.81M
Change in Accured Expenses (Quarter)
-0.02M-0.54M0.54M0.21M-0.21M-0.00M0.23M-0.05M-0.25M-0.08M0.40M-0.60M0.19M0.40M-0.39M0.27M0.30M-0.17M
Other Working Capital Changes (Quarter)
-0.35M-0.21M-0.08M-0.24M-0.37M-0.29M0.01M-0.00M-0.00M-0.01M0.06M2.62M-0.23M-0.54M-0.46M0.41M-0.77M0.14M
Investing Activities
Capital Expenditures (Quarter)
0.12M0.07M0.01M0.00M0.01M0.05M0.01M
Divestments (Quarter)
Cash from Investing Activities (Quarter)
0.20M0.05M-0.05M-10.00M9.69M-0.12M-0.07M-0.01M-0.00M-0.01M-0.05M-0.01M
Financing Activities
Other financing activities (Quarter)
-2.25M-0.00M0.00M4.98M-4.98M0.00M0.00M0.01M0.01M
Cash from Financing Activities (Quarter)
1.25M2.00M1.50M1.50M2.00M1.00M1.50M10.09M-0.01M0.00M-0.01M2.73M5.37M0.09M5.03M4.92M5.57M6.44M0.48M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
9.50M4.92M0.02M
Additional items
Exchange Rate Effect (Quarter)
-0.01M
Change in Cash (Quarter)
-0.19M0.12M-0.15M-0.14M0.25M-0.24M0.18M9.38M-1.19M-1.14M0.04M1.14M-2.64M-2.88M0.44M0.59M1.77M2.58M-5.56M
Free Cash Flow (Quarter)
-1.78M-1.79M-1.74M-1.64M-1.75M-1.24M-1.32M-0.71M-0.86M-1.14M0.05M-1.59M-8.01M-2.96M-4.59M-4.32M-3.80M-3.84M-6.05M
Net Cash Flow (Quarter)
-0.33M0.26M-0.29M-0.14M0.25M-0.24M0.18M-0.62M8.81M-1.14M0.04M1.14M-2.64M-2.88M0.44M0.59M1.77M2.60M-5.57M